The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain
about
sameAs
Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarraysCommon and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse modelCDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer.B-myb is a gene implicated in cell cycle and proliferation of breast cancerMicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.Differential network analysis applied to preoperative breast cancer chemotherapy response.B-Myb, cancer, senescence, and microRNAs.Cooperation between p27 and p107 during endochondral ossification suggests a genetic pathway controlled by p27 and p130.MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.The transcription factor B-Myb is essential for S-phase progression and genomic stability in diploid and polyploid megakaryocytes.Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.Temperature-dependent modification and activation of B-MYB: implications for cell survival.Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
P2860
Q24814806-802CF25D-31DF-42EB-A694-39169A62DBE7Q28588011-CD3F7AEA-0E56-4BEB-AB0A-442101E7F296Q33322932-9CEDA7DD-E6B3-4CB2-A738-ED65D79F041BQ34371386-48C1A7B6-F815-467F-B540-9BEA816FF8B7Q34570975-6D7D63B0-6285-4B33-A6E4-9589F198A2A0Q35069778-FCD0BAB0-FEF6-477B-A425-F89D88F3BA32Q35164933-A194CA99-165D-4BAB-9B5D-ADAE4A1C6D57Q35949581-4A4E9FDF-EC3F-4A46-94B6-4DC5F0187993Q38668036-30AB8116-98C3-442D-93B3-638296440E54Q40301477-37155F9D-E68E-43C3-BEA2-E4C6C1725242Q46455601-B331765C-8A06-4115-A8B0-8CEF7E3DD2A5Q52561894-DEE53AE3-F70F-455A-861F-CB3FDDAF6E6CQ52721971-E68AA37D-4D1D-4F7E-87FE-354ECBB7F8C1
P2860
The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@ast
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@en
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@nl
type
label
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@ast
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@en
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@nl
prefLabel
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@ast
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@en
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@nl
P2860
P356
P1476
The cell cycle-regulated B-Myb ...... with its cyclin-binding domain
@en
P2093
Roger J Watson
P2860
P304
44255-44264
P356
10.1074/JBC.M308953200
P407
P50
P577
2003-08-28T00:00:00Z